查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598784

上游生物加工市场：按产品、工作流程、使用类型和模式 - 2025-2030 年全球预测

Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年上游生物加工市场估值为107亿美元，预计2024年将达120.9亿美元，复合年增长率为13.54%，到2030年将达260.3亿美元。

上游生物加工涵盖生物技术的早期阶段，其中培养和操纵细菌、酵母和哺乳动物细胞等生物体以生产所需的生物物质。此应用对于生物製药、疫苗、生质燃料和酵素的生产至关重要。我们需要优化细胞生长条件，确保所需产品的高产量和高品质，并满足对生物疗法药物日益增长的需求。最终用途领域包括製药和生物技术公司、研究机构和受託製造厂商。该领域的成长是由基因工程的进步、慢性病的流行以及个人化医疗的扩展所推动的。新兴趋势包括自动化和流程分析的集成，以提高效率和扩充性，从而提供巨大的成长机会。为了抓住这些机会，鼓励公司投资先进的反应器技术和上游处理系统，以实现即时监控和控制。然而，高营运成本、复杂的监管要求以及对熟练人员的需求等挑战可能会阻碍市场成长。此外，还需要可扩展且具成本效益的解决方案，以及製定强有力的污染控制措施。解决这些限制需要在更灵活、风险更低的一次性技术和一次性反应器领域持续创新。研究和开发重点还可以致力于改善细胞株开发和代谢工程，以确保提高产品的一致性和产量。市场动态是动态的，其特点是技术的快速进步和对永续实践的重视。希望利用市场趋势的公司应优先考虑与学术机构和技术提供者的合作，并强调共同创新以保持竞争优势。

主要市场统计
基准年[2023] 107亿美元
预测年份 [2024] 120.9亿美元
预测年份 [2030] 260.3亿美元
复合年增长率（%） 13.54%

市场动态：揭示快速发展的上游生物加工市场的关键市场洞察

上游生物加工市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对生物治疗药物的需求不断增长
    • 扩大过程分析技术（PAT）的引进
    • 一次性使用的快速普及
  • 市场限制因素
    • 上游加工设备安装维护成本高
  • 市场机会
    • 生物相似药的接受度和核准提高
    • 扩大细胞治疗、细胞库、药物发现和重组蛋白的上游工程应用
  • 市场挑战
    • 与标准上游生物过程监测相关的能力限制

波特五力：驾驭上游生物加工市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解上游生物加工市场的外部影响

外部宏观环境因素在塑造上游生物加工市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解上游生物製程市场的竞争格局

对上游生物加工市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 上游生物加工市场中的定位矩阵供应商绩效评估

FPNV定位矩阵是评估上游生物加工市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製上游生物加工市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对上游生物加工市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生物製药需求增加
      • 扩大过程分析技术（PAT）的引进
      • 快速引入一次性上游生物工艺
    • 抑制因素
      • 安装和维护上游处理装置的成本高昂
    • 机会
      • 生物相似药的接受度和核准提高
      • 增加上游製程在细胞治疗、细胞库、药物发现及重组蛋白的应用
    • 任务
      • 与标准上游生物过程监测相关的功能限制
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章上游生物加工市场：副产品

  • 袋子和容器
  • 反应器和发酵罐
  • 反应器配件
  • 细胞培养产品
  • 筛选

第七章上游生物加工市场：依工作流程

  • 细胞培养
  • 细胞分离
  • 媒体准备

第八章上游生物加工市场：依使用类型

  • 多才多艺的
  • 一次性的

第九章上游生物加工市场：依模式

  • 公司内部
  • 外包

第十章美洲上游生物处理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太上游生物加工市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲上游生物加工市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Boehringer Ingelheim International GmbH
  • Danaher Corporation
  • Eppendorf AG
  • Esco Micro Pte. Ltd
  • GE Healthcare
  • Getinge AB
  • High Purity New England
  • Lonza Group AG
  • Meissner Filtration Products, Inc.,
  • Merck KGaA
  • Rentschler Biopharma SE
  • Samsung BioLogics
  • Sartorius AG
  • Tornado Spectral Systems
  • Waters Corporation
Product Code: MRR-A26E0E574508

The Upstream Bioprocessing Market was valued at USD 10.70 billion in 2023, expected to reach USD 12.09 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 26.03 billion by 2030.

Upstream bioprocessing encompasses the initial stages of biotechnology where living organisms such as bacteria, yeast, and mammalian cells are cultivated and engineered to produce desired biological materials. The application is critical for producing biopharmaceuticals, vaccines, biofuels, and enzymes. Its necessity lies in optimizing cell growth conditions, ensuring high yield and quality of the target product, and addressing increasing demands for biotherapeutics. End-use sectors include pharmaceutical and biotechnology companies, research institutions, and contract manufacturing organizations. Growth in this field is driven by advancements in genetic engineering, increasing prevalence of chronic diseases, and the expansion of personalized medicine. An emerging trend is the integration of automation and process analytics which enhances efficiency and scalability, offering a significant potential opportunity for growth. To seize these opportunities, companies are advised to invest in advanced bioreactor technologies and upstream processing systems that enable real-time monitoring and control. However, challenges such as high operational costs, complex regulatory requirements, and the need for skilled personnel may impede market growth. Moreover, scalable and cost-effective solutions are necessary, alongside developing robust contamination control measures. To address these limitations, ongoing innovation is required in the areas of disposable technologies and single-use bioreactors, which can offer more flexibility and lower risk. Research and development focus can also pivot towards improving cell line development and metabolic engineering, ensuring better product consistency and yield. The nature of the upstream bioprocessing market is dynamic, characterized by rapid technological advancements and a strong emphasis on sustainable practices. Businesses aiming to capitalize on market trends should prioritize partnerships with academic institutions and technology providers, emphasizing collaborative innovation to maintain competitive advantages.

KEY MARKET STATISTICS
Base Year [2023] USD 10.70 billion
Estimated Year [2024] USD 12.09 billion
Forecast Year [2030] USD 26.03 billion
CAGR (%) 13.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Upstream Bioprocessing Market

The Upstream Bioprocessing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for biotherapeutics
    • Growing implementation of process analytical technology (PAT)
    • Rapid adoption of single-use upstream bioprocessing
  • Market Restraints
    • High cost of establishing and maintaining an upstream processing unit
  • Market Opportunities
    • Increased acceptance and approvals of biosimilars
    • Rising application of upstream process in cell therapy, cell banking, drug discovery, and recombinant proteins
  • Market Challenges
    • Limitations to its capabilities related to standard upstream bioprocess monitoring

Porter's Five Forces: A Strategic Tool for Navigating the Upstream Bioprocessing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Upstream Bioprocessing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Upstream Bioprocessing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Upstream Bioprocessing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Upstream Bioprocessing Market

A detailed market share analysis in the Upstream Bioprocessing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Upstream Bioprocessing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Upstream Bioprocessing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Upstream Bioprocessing Market

A strategic analysis of the Upstream Bioprocessing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Upstream Bioprocessing Market, highlighting leading vendors and their innovative profiles. These include Boehringer Ingelheim International GmbH, Danaher Corporation, Eppendorf AG, Esco Micro Pte. Ltd, GE Healthcare, Getinge AB, High Purity New England, Lonza Group AG, Meissner Filtration Products, Inc.,, Merck KGaA, Rentschler Biopharma SE, Samsung BioLogics, Sartorius AG, Tornado Spectral Systems, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Upstream Bioprocessing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories, Cell Culture Products, and Filters.
  • Based on Workflow, market is studied across Cell Culture, Cell Separation, and Media Preparation.
  • Based on Use Type, market is studied across Multi-Use and Single-Use.
  • Based on Mode, market is studied across In-House and Outsourced.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for biotherapeutics
      • 5.1.1.2. Growing implementation of process analytical technology (PAT)
      • 5.1.1.3. Rapid adoption of single-use upstream bioprocessing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of establishing and maintaining an upstream processing unit
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased acceptance and approvals of biosimilars
      • 5.1.3.2. Rising application of upstream process in cell therapy, cell banking, drug discovery, and recombinant proteins
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations to its capabilities related to standard upstream bioprocess monitoring
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Upstream Bioprocessing Market, by Product

  • 6.1. Introduction
  • 6.2. Bags & Containers
  • 6.3. Bioreactors & Fermenters
  • 6.4. Bioreactors Accessories
  • 6.5. Cell Culture Products
  • 6.6. Filters

7. Upstream Bioprocessing Market, by Workflow

  • 7.1. Introduction
  • 7.2. Cell Culture
  • 7.3. Cell Separation
  • 7.4. Media Preparation

8. Upstream Bioprocessing Market, by Use Type

  • 8.1. Introduction
  • 8.2. Multi-Use
  • 8.3. Single-Use

9. Upstream Bioprocessing Market, by Mode

  • 9.1. Introduction
  • 9.2. In-House
  • 9.3. Outsourced

10. Americas Upstream Bioprocessing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Upstream Bioprocessing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Upstream Bioprocessing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Boehringer Ingelheim International GmbH
  • 2. Danaher Corporation
  • 3. Eppendorf AG
  • 4. Esco Micro Pte. Ltd
  • 5. GE Healthcare
  • 6. Getinge AB
  • 7. High Purity New England
  • 8. Lonza Group AG
  • 9. Meissner Filtration Products, Inc.,
  • 10. Merck KGaA
  • 11. Rentschler Biopharma SE
  • 12. Samsung BioLogics
  • 13. Sartorius AG
  • 14. Tornado Spectral Systems
  • 15. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. UPSTREAM BIOPROCESSING MARKET RESEARCH PROCESS
  • FIGURE 2. UPSTREAM BIOPROCESSING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. UPSTREAM BIOPROCESSING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. UPSTREAM BIOPROCESSING MARKET DYNAMICS
  • TABLE 7. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BAGS & CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BIOREACTORS & FERMENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BIOREACTORS ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL CULTURE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY FILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MULTI-USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 191. UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023